Literature DB >> 3367136

Immune response to hepatitis B revaccination.

W Jilg1, M Schmidt, F Deinhardt.   

Abstract

Two hundred and twelve individuals who failed to respond or responded poorly to hepatitis B vaccination or whose anti-HBs levels had dropped below 10 IU/L at follow-up were revaccinated. Only 18% of initial nonresponders, but 96% of those who responded initially, developed anti-HBs above 10 IU/L after revaccination. In 85% of vaccinees, anti-HBs titres after a fourth immunization were significantly higher than after completion of the first full immunization course, and despite a steeper decline of antibody levels after revaccination, anti-HBs seemed to persist better than after the initial course of three inoculations. All individuals who responded initially and in whom anti-HBs had become undetectable developed antibodies. Response to booster doses was seen after three to five days, and a fifth inoculation given to 23 individuals induced even better responses.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3367136     DOI: 10.1002/jmv.1890240404

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  A 12-year cohort study on the efficacy of plasma-derived hepatitis B vaccine in rural newborns.

Authors:  Hong-Bin Liu; Zong-Da Meng; Jing-Chen Ma; Chang-Quan Han; Ying-Lin Zhang; Zhan-Chun Xing; Yu-Wei Zhang; Yu-Zhong Liu; Hui-Lin Cao
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Four-year experience with a recombinant hepatitis B vaccine.

Authors:  W Jilg; M Schmidt; F Deinhardt
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

3.  Strategies for hepatitis B infection.

Authors:  P J Wismans; J van Hattum
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

Review 4.  Traditional management of liver disorders.

Authors:  M Messner; P Brissot
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 5.  Chronic Viral Hepatitis in Elite Athletes: Approaches to Risk Assessment, Prevention and Management.

Authors:  Lung-Yi Mak; Ian Beasley; Patrick T F Kennedy
Journal:  Sports Med Open       Date:  2022-10-04

6.  Seroprevalence of hepatitis B virus among health care workers in Korea.

Authors:  Bo-Moon Shin; Hyeon Mi Yoo; Ae Sook Lee; Sang Keun Park
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

7.  Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence.

Authors:  Marianne A B van der Sande; Pauline A Waight; Maimuna Mendy; Syed Zaman; Steve Kaye; Omar Sam; Abi Kahn; David Jeffries; Aveika A Akum; Andrew J Hall; Ebrima Bah; Samuel J McConkey; Pierre Hainaut; Hilton C Whittle
Journal:  PLoS One       Date:  2007-08-15       Impact factor: 3.240

8.  Efficacy of double dose recombinant hepatitis B vaccination in chronic hepatitis C patients, compared to standard dose vaccination.

Authors:  Mohammad Minakari; Afshin Tahmasebi; Mahyar Hosseini Motlagh; Behrooz Ataei; Majid Yaran; Hamid Kalantari; Hamid Tavakkoli
Journal:  Int J Prev Med       Date:  2014-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.